Ugur Sahin, Chief Executive Officer of BioNTech SE (BNTX), sold 72,000 shares of the company's stock on October 5, 2026, for approximately $7.00 million. The shares were sold at an average price of $97.23 per share.
This transaction is part of a series of sales by Sahin in early October, totaling over 160,000 shares and exceeding $15 million in value. Insider sales can be attributed to various reasons, including portfolio diversification, tax planning, or adherence to pre-arranged trading plans, and do not necessarily indicate a negative view of the company's prospects.